Fluvoxamine Helps Lower Risk of Hospitalization From Covid, Study Finds
Scientists say the results of the latest research examining the inflammation-fighting qualities of fluvoxamine, capping similar smaller studies, could lead to new treatment guidelines.
View original article
Contributor: Benjamin Mueller
